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ABSTRACT

EVALUATION AND IMPROVEMENT OF A NOVEL METHOD FOR RAPID
PROMOTER CHARACTERIZATION IN A ZEBRAFISH MODEL

Hunter Harrison Giles
Molecular and Microbiology
Bachelor of Science

This thesis examines a novel technique for characterizing promoters using a
zebrafish model. The proximal upstream cis-regulatory elements, also known as
promoters or promoter regions, are essential for the precise regulation and timing of gene
expression. Often the characterization of these regions relies on imprecise methods
involving large deletions or bioinformatic predictions rather than experimental data.
However, high-throughput sequencing technology could potentially allow large libraries
containing hundreds of thousands of variants of a single promoter to be simultaneously
analyzed. We have been working to develop a novel method for promoter
characterization that takes advantage of this technology. We tested this method by
producing a variant library of the zebrafish cardiac myosin light chain-2 gene (cmlc2)
promoter, then used those variants to drive expression of a degenerate barcode in the 5’
UTR of gfp. We found that tracking the relative expression levels of the barcodes allowed
us to successfully characterize the cmlc2 promoter in line with a previously published
analysis using less precise techniques. Our method also led to discoveries of additional
sites of gene regulation within the cmlc2 promoter. We next designed improvements to
iii

the process to improve workflow and adaptability to other promoters. We tested these
improvements with the zebrafish ventricular myosin heavy chain (vmhc) promoter.
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I. Background
Understanding the mechanics of transcription factor binding to promoters is
important to understanding genetic disease. Variations in the promoter can have serious
consequences in either upregulating or downregulating gene expression. A 2009 review
article (Epstein, 2009) indicated the importance of cis-regulatory regions on various
genetic diseases such as Hemophilia B, osteoporosis, and thalassemia (a blood disorder).
Each of these diseases was linked to SNPs in the cis-regulatory sequences (Epstein,
2009). This paper suggested that better understanding of promoters could lead to better
identification of the underlying factors driving disease. In 2013, researchers at Harvard
and the Broad Institute applied this principle by examining the promoter of telomerase
reverse transcriptase (TERT). They found that 70% of the melanomas examined
contained SNPs in the promoter that conferred two- to four-fold increases in gene
expression (Huang F. et al., 2013). The researchers also found similar mutations in the
TERT promoters from various other cancer cell lines, suggesting that these mutations
may be important for driving cancer development. Although this is an example of a
somatic mutation, understanding and mapping germline cis-regulatory regions for
oncogenes will help identify potential impacts of SNPs. Understanding the impacts of
promoter variants can lead to more personalized medicine and the development of other
therapies aimed at countering the effects of gene misregulation.
Although the characterization of promoters is important to understanding genetic
disease, strategies for doing so are often costly or laborious. Past methods of promoter
characterization have included quantifying the fluorescence from reporter genes driven
by various promoters (Kelly et al., 2009) and then comparing the transcription factor
1

binding sites within those promoters, although this was shown to suffer from variations in
the environmental conditions of the host cells (Rudge et al., 2016). Another method
involves creating promoter constructs by deleting large segments (~100 bp) within the
promoter (Zhao et al., 2016; Hill et al., 2010; Wallich et al., 1998). While effective in
determining minimal active promoters, this approach lacks the precision necessary to
elucidate effects of SNPs, such as the SNPs involved with the diseases mentioned above.
A third strategy for promoter analysis consists of deleting small targets already suspected
to be binding sites (Zhuang et al., 2013). Although much more precise, this method often
relies on bioinformatic analysis of upstream sequences. These bioinformatic analyses,
however, struggle to correctly identify which tissue-specific enhancers will be active in a
certain cell (Herman-Izycka et al., 2017). Further difficulties arise when attempting to use
this method to characterize large promoters because of the labor required to perform
multiple iterative rounds of deletions to achieve coverage across the entire promoter. This
difficulty hinders discovery of unknown transcription factor binding sites because
transcription factors only bind short sequences of DNA about 10 base-pairs long, and
these binding sequences may have degenerate bases that are equally acceptable (Stewart
et al., 2012). None of these strategies provides an adequate method for rapid
characterization of promoters in order to expand the current literature on genetic
regulation.
The need for improvements to current methods of promoter analysis was
recognized by the authors of a Nature Biotechnology paper titled “Massively Parallel
Functional Dissection of Mammalian Enhancers in vivo” (Patwardhan et al., 2012). The
researchers developed a method to analyze enhancer regions at single base resolution by
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creating mutated enhancer libraries, adding those enhancers to a minimal promoter to
drive luciferase and a degenerate tag, injecting those constructs into mice tail veins, then
measuring the fold-change expression levels of the luciferase gene in the mouse livers
through RT-PCR and sequencing of the degenerate tags. They found this method to be
highly effective for identifying the effects of mutations at each nucleotide position within
the previously identified enhancer regions. They then compared the effects they found
with previously reported binding sites of known transcription factors.
While an extremely important development for improving promoter
characterization strategies, the study acknowledged several limitations. First, the authors
noted that their strategy resulted in extremely low levels of RNA compared to the overall
levels of RNA in the extracted liver tissues, which may have affected the precision of the
assay. Second, the methodology can only be used to characterize cis-regulatory regions
active in the liver because the tail-vein injected constructs were only taken up by
hepatocytes. Lastly, the enhancers were episomal rather than incorporated into the
chromosomes, so regulation might function differently for promoter sequences
incorporated into chromosomal DNA.
The Hill lab has identified potential strategies for improving the first and second
limitations identified in the study in order to further develop a method for single base-pair
resolution analysis of entire promoters. We propose using a zebrafish model to achieve
these improvements. First, by using zebrafish embryos, it is possible to inject the
promoter constructs at the single-cell stage. Injecting at the single-cell stage is important
for expanding our analysis method beyond the limitation of liver promoters; promoters
specific to any tissue type could be injected at the single cell stage and then drive
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expression in their target cells. As the embryo divides, the injected promoter library
plasmids are distributed throughout all of the cells. Using zebrafish embryos also
addresses the second limitation mentioned above because direct injection, rather than
absorption from the bloodstream, increases the amount of plasmid library inside the
target cells. This results in a greater percentage of expressed plasmid RNA compared to
total RNA isolated from the developing embryos. We also isolate the RNA from a small
sample of embryonic tissue rather than an entire adult mouse liver. Thus, we believe that
using zebrafish allows for more efficient promoter and enhancer analysis.
The ultimate goal of this method is to be able to analyze promoters for human
genes involved in genetic disease. Although it may seem counter-intuitive to use
zebrafish rather than mice for that goal, we can use zebrafish because most transcription
factors are conserved between mammals and zebrafish (Ung et al., 2010). In addition,
while general DNA sequences vary between species, transcription factor binding motifs
are conserved across species (Stewart et al., 2012). This is because a single transcription
factor will bind at thousands of places throughout a genome. This need to recognize
binding sites throughout a genome places evolutionary pressure against mutations in the
binding domains of the transcription machinery because a slight change would affect the
expression of thousands of genes. We also believe using the zebrafish model will be
faster than mouse models because of the relative ease of breeding zebrafish compared to
mice and the accessibility of the embryo. Zebrafish development is also extremely rapid
(Kimmel et al., 1995). For example, the experiment described here used promoters
endogenous to heart tissue, which can be analyzed at the midpoint of heart development
(48 hours post fertilization (hpf)) (Kimmel et al., 1995).
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We tested our analysis method using the cmlc2 promoter in zebrafish. This
promoter is known to drive gene expression in the heart, faithfully recapitulating the
endogenous cmlc2 expression pattern (Huang C. et al., 2003). Huang C. et al. created a
transgene, using a 904 base-pair promoter (870 bases upstream and 34 bases downstream
of the transcription start site), to drive gfp expression in zebrafish and found expression
isolated to the myocardium tissue. Using different lengths of upstream sequence, intron 1,
and exons 1 and 2, they built thirteen different constructs. From these, they determined
the minimal promoter was contained from nucleotides -210 to 34. However, they also
recognized that a promoter construct spanning from -870 to 34 shared similar expression
levels, and both of these fragments expressed gfp at higher levels than constructs
containing a mutation at position -701. This suggests that while the shorter construct was
sufficient, there may be additional regulatory elements further upstream. For our project,
we tested the entire 904 base-pair region.
The aim of this thesis was to complete a proof of concept test with the cmlc2
promoter. Once this initial proof of concept experiment finished, we additionally aimed
to streamline the process to create a universal protocol that could be used to characterize
any promoter. We tested the new streamlined process design using the zebrafish vmhc
gene promoter. The vmhc gene is similar to cmlc2 but is only expressed in the heart
ventricle whereas cmlc2 is expressed throughout the heart.

5

II. Project Overview
An overview of the entire workflow used to implement our method is found in figure 1:

a

b
Create plasmid
library

Sequence plasmids to
define mutations

f

e

d

Database of barcoded
mutations

c

AAAA
AAAA
AAAA
AAAA

Inject and grow fish

Isolate mRNA
and run RNA-seq

Plot read counts by promoter
position mutated

Figure 1. Project Overview (a) The plasmid is created through Gibson cloning fragments
of mutated promoters (black bars; red stars indicate point mutations), unique barcodes
(colored bars) and gfp (green bars). In (b), an aliquot of the plasmid library is sequenced to
pair mutations and barcodes in a database (c), while a second library aliquot is injected
into zebrafish (d). RNA-seq (e) of the expressed gfp produces frequencies for each
barcode, which are then paired back to mutation positions and plotted to determine effects
of SNPs on barcode expression (f).

The first step is the creation of the plasmid library (figure 1a). We started by
amplifying each fragment to be incorporated into a plasmid. Each plasmid in the library
needed to contain a randomly mutated cmlc2 promoter as well as an enhanced green
fluorescent protein (gfp) reporter gene and a degenerate barcode. The degenerate
barcodes were incorporated into the 5’ UTR of gfp.
The promoter was amplified by mutagenic PCR to introduce sequence variation.
We chose to analyze the -870 to +34 base region of the cmlc2 promoter, which is the
same region analyzed by Huang C. et al. (2003). As our goal was to achieve single
6

nucleotide specificity throughout the entire 904-base sequence, it was important to use a
mutagenic PCR protocol with a carefully controlled error rate. Our target was an average
of one or two point mutations per promoter. We aimed to produce this error rate by using
Taq polymerase, which is inherently error prone (Potapov et al., 2017) and can be finetuned by varying salt concentration in the reaction mixture (Takara Bio USA, Inc). To
have mutations at each position we needed a minimum of several thousand promoter
variants of cmlc2, but we planned to have a much larger number of variants to ensure
complete coverage. One limitation of using mutagenic PCR to introduce mutations is that
this process selects against mutations at the 5’ end of the promoter where the PCR primer
binds. Our primer annealed to the first 40 bases of the promoter, so we did not expect to
see many mutations at those positions.
For the second fragment, gfp, we did not need random mutations. Thus, rather
than the mutagenic PCR conditions with Taq DNA polymerase, the gfp was amplified
using phusion high-fidelity DNA polymerase (New England Biolabs, Phusion). The
primers used to amplify the gfp also contained a degenerate 15 base-pair barcode at the 5’
end. The barcode sequence was 5’-GNNGNNGNNGNNGNN, where the first base of
each codon in the reading frame was guanine in order to prevent an accidental stop codon
from triggering nonsense mediated RNA decay. The barcode was 15 bases long in order
to accommodate these invariable bases but still provide enough variation (410 = 1,048,576
possible barcode sequences) so each promoter variant could be paired with a unique
barcode.
Once both the promoter and gfp fragments were amplified in their separate PCRs,
they could be simultaneously cloned into a plasmid backbone using Gibson cloning (New
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England Biolabs, Gibson). The plasmid backbone began as the pCR4-TOPO plasmid
(Addgene) but was amplified with primers in order to create a linearized vector. Gibson
cloning involved combining both fragments along with the destination vector in a 2:2:1
ratio of cmlc2promoter:gfp:vector (New England Biolabs, Gibson Clone).
The second step is library annotation and verification (figure 1b and c). After the
library was assembled, an aliquot was sent for PacBio sequencing (figure 1b). This
sequencing served as a validation of the mutagenic PCR protocol to ensure that each
promoter would only have an average mutation frequency between one and two point
mutations. Because of our desired low error rate of one to two mutations per promoter,
we also expected that many promoters would not have any mutations. These reference
sequence promoters served as a built-in control to drive a baseline barcode expression
level to which we could compare the differentially expressed barcodes driven by
promoter variants. For the promoters that did contain mutations, the PacBio sequencing
identified the position of each mutation within the promoter and then paired that specific
promoter sequence with a unique barcode (from the gfp fragment). This enabled us to
assemble a database of promoter mutations and corresponding barcodes for our library
(figure 1c).
The third step in our method is injection of the library into zebrafish (figure 1d).
A second aliquot of the library was injected into zebrafish embryos at the single-cell
stage (figure 1d). Following a protocol from Ablain et al. (2015), we diluted the plasmid
library to 24 ng/uL for injections of roughly 20 pg of plasmid per embryo. Although it is
unknown exactly how many plasmids from this injection made it into the heart cells,
Ablain et al. (2015) showed that injecting this quantity of a CRISPR/Cas9 vector

8

targeting myocardial expression of transgenic gfp into single-cell stage zebrafish embryos
resulted in successful disruption and lack of expressed myocardial gfp. This finding
indicates that sufficient quantities of the vector persist through each round of cell division
to have a measurable effect in the heart tissues, so we hypothesized that our injection
would follow a similar pattern.
By 48 hpf, the zebrafish heart is beating (Kimmel et al., 1995) and the cellular
machinery is transcribing the endogenous cmlc2. We believed 48 hours also allowed
sufficient time for all plasmid constructs to be expressed. Because Patwardhan et al.
(2012) found extremely low levels of barcode expression, we chose to isolate only heart
tissues to reduce the amount of contaminating endogenous zebrafish RNA. The extracted
RNA was converted to cDNA using primers that targeted the 5’ UTR so we isolated
DNA fragments containing the barcode.
The final step of this method is barcode sequencing (figure 1e). Barcode
fragments were amplified by RT-PCR and then sent for sequencing (figure 1e). Resulting
sequences were then processed to extract the barcodes and paired with the promoter
variant/barcode database we assembled from the original PacBio sequencing data. By
plotting the relative frequencies of each barcode (figure 1f) and its corresponding
mutation position, we found the effects of each mutation on expression level.
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III. Results and Analysis
cmlc2 Promoter
We began by amplifying the gfp, promoter, and plasmid sequences for
incorporation into the plasmid library. We performed Gibson cloning, then replicated the
library and sent an aliquot to be sequenced using PacBio HiFi sequencing. As expected,
the sequencing revealed both the frequency and location of the mutations. The results are
shown in figure 2.
a
c

Figure 2. Number of Mutations
and Position within cmlc2
promoter. (a) The upper-left
panel shows the frequency of
each number of mutations per
promoter when aligning the
sequencing data back to the
reference cmlc2 promoter. The
lower-left panel (b) is a plot of
the position of each mutation in
the sequence results when
aligned back to the reference
sequence. (c) is a diagram
showing the assembled plasmid
with mutated cmlc2 promoter
and gfp sequences cloned into the
PCR4 vector

b

In panel 2a, we see confirmation that the mutagenic PCR resulted in the majority
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of cmlc2 promoters having 2 or less mutations. The average number of mutations per
promoter was 1.88, with a median mutation level of 1 SNP. This indicates that our
mutagenic PCR protocol was appropriately tuned to generate the correct error rate. We
also see that many promoters are perfectly aligned with the reference sequence (zero
mutations). This confirmed our plan to have built-in controls. In panel B, we see the
position of each mutation within the cmlc2 promoter. There was an average coverage of
50 variants per base-position throughout the 904 bases, giving us over 40,000 promoter
variants in our small aliquot. This far exceeded the minimum number necessary to
provide sufficient coverage at each position and ensured that the library we injected
provided coverage throughout the entire promoter. The relatively few mutations within
the first 40 bases indicates where the primers for PCR amplification annealed. Mutations
occurring in that region discouraged future annealing.
At this point, I began work to complete the proof of concept analysis using the
cmlc2 promoter. We next injected an aliquot of the plasmid library into zebrafish
embryos at the single-cell stage to confirm that the plasmid would successfully reach the
heart and still be expressed. After 48 hours, gfp was observed in a mosaic expression

Figure 3. gfp Expression gfp expression driven by cmlc2 promoter variants was evident in zebrafish at
48 hpf
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pattern, confirming the presence of plasmids in the myocardium (see figure 3). Although
this expression was visible, we injected a separate aliquot into cmlc2:gfp transgenic fish
in order to facilitate easier heart-tissue collection. Using these fish allowed collection of
not only heart tissues that contained highly expressing plasmids, but also collection of
heart tissues with weakly expressing plasmids that would not have produced enough gfp
to be visible.
The zebrafish heart tissues were extracted from roughly 80 embryos and the
mRNA was isolated. Although this did not represent the entire injected library, we
expected this sample would be sufficient to provide coverage across the entire promoter
or at least provide a reference point in our proof of concept trial. Using primers specific
for amplification of the 5’ end of gfp (the barcode region) we converted the extracted
mRNA into cDNA. The barcode region was then amplified and sent for Illumina
sequencing.
The sequencing results were filtered to only those containing 15-base barcodes,
removing any contaminating gfp 5’ UTR from the zebrafish’s transgenic gfp. This
produced 105,759,882 different barcode reads, with 146,474 unique barcodes identified.
Of this set, 3% had corresponding barcodes in the library sequencing data. Although we
expected less than 100% since we only sequenced an aliquot of the original library, this
low barcode concurrence suggests that in future promoter analyses we will need to
sequence more of the original library to build a more complete database. The barcodes
that did have matches were paired with their corresponding promoter sequence mutations
and then plotted by frequency. The resulting data is shown in Figure 4. We realized that
some bias may have occurred due to uneven distribution of mutations at different
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Figure 4. Relative Barcode Expression versus Mutation Position The frequency of each barcode
sequence is plotted as a function of the positions of mutations in the corresponding promoter
sequences. The highlighted blue area corresponds to a 99% confidence interval for the mean
expression level of the barcodes corresponding to cmlc2 promoters without any mutations.

positions in the promoter. To reduce that bias, we took the mean expression frequency of
all barcodes corresponding to mutations at a single position rather than the absolute
expression frequencies. To further smooth the data, we used a sliding window mean with
a 10 base-pair window. We chose ten bases since that is a common binding size for
transcription factors (Stewart et al., 2012).
In order to determine which regions of promoter variation produced statistically
significant effects, we established a 99% confidence interval for the baseline expression
level. In the barcodes extracted from the RNA-seq data, we found 1,784 barcodes that
corresponded to promoters with zero mutations. These sequences came from the internal
controls established during the PacBio library sequencing when we identified barcodes
attached to reference sequence promoters. The expression levels of these barcodes
provided us with a range where we expected average natural variation to occur. Mean
13

expression levels outside of that range indicate significant changes in the expression
pattern caused by the mutations we introduced. Wherever the plot of expression levels
drops below the highlighted blue area marking the baseline expression level, we would
expect to find activator binding sites. On the other hand, peaks that rise above the
highlighted baseline expression levels may mark sites for repressors that are involved
with gene regulation. It appears that important enhancer binding sites occur within the
first 30 bases of the promoter as well as at positions -860, -750, -540, -350, -280, and
-245. These peaks likely represent binding sites for various transcription factors
necessary to drive gene expression. The drop of expression around -875 may be more of
an artifact of the fewer number of variants with mutations in that region due to the primer
binding. The region from -560 to -615 also appears to have a significant role in regulation
since mutations anywhere in that region allow for upregulation.
We also see upregulation around positions -710, -440, -310, -250, -225, and -175.
These are likely the binding sites of inhibitory factors that regulate gene expression either
temporally or spatially.
These results both concur with and improve the findings by Huang C. et al.
(2003). The most critical area for gene expression (deepest drop in relative expression)
appears to be around nucleotide position -25, which corresponds to the putative
Polymerase II binding region and a TATA box. We also see several other drops within
the first 200 bases, aligning with Huang C. et al.’s finding that the essential promoter is
contained within 210 bases upstream from the cmlc2 gene. However, we see many
additional regulatory elements in the area spanning 200 to 800 bases upstream from the
gene, including from -200 to -310 where there are several downregulated variants as well
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as many upregulated variants. Overall, a deletion of this entire region, such as done by
Huang et al., might have masked the individual differential expressions and resulted in an
overall baseline expression level. Further upstream, Huang C. et al. noted that certain
constructs drove gfp expression in tissues beyond the heart, such as constructs with a
mutation at -710. We also see an upregulation of barcode expression, suggesting that
some of the upregulation of these barcodes could have been caused by non-myocardium
specific expression rather than actual upregulation. These constructs could have entered
the sample because they would have fluoresced along with the fluorescent heart tissues.
While further analysis of these results is needed, this sequencing data provides
encouraging evidence for the validation of this new technique.

vmhc Promoter
Next, we set out to improve our promoter analysis method in order to reduce the
time required for library generation. Although effective, using the Gibson cloning method
to construct a plasmid library with 40,000 different variants was difficult and laborious.
To eliminate this difficulty, we proposed to use a Golden Gate cloning technique, which
is a faster and more efficient method for vector construction (Engler et al., 2008).
The Golden Gate cloning method takes advantage of type IIS restriction enzymes,
which cut outside their binding sites and leave variable 5’ overhangs. These overhangs
facilitate downstream ligation in the correct orientation and order. Although there are
many type IIS restriction enzymes, we chose to use BsmB1. This restriction enzyme cuts
one base-pair away from its recognition site and leaves a four-base 5’ overhang (New
England Biolabs. BsmB1 Datasheet).
15

a
gfp

NNN AGCG NAGAGCG 3’
NNN TCGC NTCTCGC 5’
BsmB1

Plasmid

NNN CCCT NAGAGCG 3’
NNN GGGA NTCTCGC 5’
BsmB1

b

c
Promoter

NNN CCAC NAGAGCG 3’
NNN GGTG NTCTCGC 5’
BsmB1

BsmB1
5’ CGTCTCN AGCG NNN
3’ GCAGAGN TCGC NNN

Plasmid

BsmB1
5’ CGTCTCN CCCT NNN Promoter
3’ GCAGAGN GGGA NNN

BsmB1
5’ CGTCTCN CCAC NNN
3’ GCAGAGN GGTG NNN

gfp

d

BsmB1
ATCGCGTCTCNCCCT
vmhc Forward Primer
ACTCCGCGGAGGCCATGTGTCCT
5’ ACTCCGCGGAGGCCATGTGTCCT……CATGGTTGGTGTTCGGATCCGAT 3’
vmhc
TGAGGCGCCTCCGGTACACAGGA……GTACCAACCACAAGCCTAGGCTA
GTACCAACCACAAGCCTAGGCTA
vmhc Reverse Primer
GGTGNCTCTGCGCTA
BsmB1

Figure 5. Golden Gate Overhang Design (a-c) The BsmB1 restriction enzyme sites. The 5’
overhangs are designed so that the fragments will assemble into the appropriate sequence. The
highlighted sequences are the overhangs that will be left when Bsmb1 cleaves itself from the 5’ end of
each fragment. Panel (d) shows the tails of the forward and reverse primers used for amplification of
the vmhc promoter with the four base overhangs and BsmB1 restriction sites in the primer tails.

To attach the BsmB1 restriction sites, we used tails containing the restriction site
sequences (see figure 5d). Using primers with tails also adapted this promoter
characterization method to a more universal application. Primers could be designed to
amplify any promoter, and the researchers would just need to add the tails we designed in
this method in order to amplify fragments ready to clone into vectors to create a plasmid
16

library. This would allow rapid characterization of any mammalian promoter that had a
similar analog in zebrafish. As an additional change to the method, we decided to move
the barcode to the 3’ end of gfp in order to eliminate any potential transcriptional
interference that may have resulted from placing the barcode in the 5’ UTR where it was
located during the cmlc2 promoter analysis. This also allowed us to remove the
interspacing G bases and reduce our entire barcode to only 10 bases
(5’-NNNNNNNNNN). This was done by incorporating a degenerate barcode along with
the BsmB1 restriction site into the primer tail:
5'ATCGCGTCTCNCGCTNNNNNNNNNNACTTGTACAGCTCGTCCATGCC-3’
In order to validate the improved promoter analysis methods, we analyzed the
ventricular myosin heavy chain (vmhc) promoter. Like cmlc2, the vmhc gene is expressed
in the heart, but only in the ventricle rather than throughout the entire myocardium. The
vmhc promoter has also been characterized. Using earlier characterization techniques of
progressively larger deletions, Jin et al. (2009) identified the minimal vmhc promoter. We
expanded this analysis by characterizing the zebrafish vmhc promoter using our new
technique. The upstream promoter analyzed by Jin et al. (2009) spanned a 1.9 kb region.
In order to compare our results to theirs, we designed primers to amplify the same 1.9 kb
section of the zebrafish genome.
We designed our overhangs such that each overhang has a unique sequence (see
figure 5). We ordered primers with the appropriate tails to add the restriction sites and
barcode (5d). In addition to the 4-base overhang and the restriction site, we also added
four bases (ATCG), so the restriction site is not located at the end of any of the DNA
fragments.
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We individually amplified the gfp, the vmhc promoter, and the plasmid vector.
For gfp and the vmhc promoter we used zebrafish genomic DNA. The vmhc gene is
endogenous to zebrafish, and our lab has access to transgenic zebrafish with gfp
incorporated into their genome. For the backbone, we used the plasmid from the cmlc2
library as our template. We designed the primers to amplify the entire vector except for
the gfp and cmlc2 promoter regions. While both the gfp and plasmid amplification was
done using a hi-fidelity phusion DNA polymerase, the vmhc promoter was amplified with
a Taq mutagenic PCR protocol that introduced an average of 1 mutation per kb. With the
1.9 kb length of the vmhc promoter, this should result in an average of 2 mutations per kb
when amplified using this mutagenic protocol. Due to the large tails on each primer, the
PCR was more difficult than originally anticipated. The gfp, for example, had a 21-base
annealing region with a 24-base tail because of the 10-base barcode, 4-base overhang we
designed, 6-base BsmB1 restriction site, and 4-base cap. After trying a variety of
temperatures and gradients without seeing consistent results, we went to a multistage
PCR strategy where the first seven cycles were a gradient PCR in order to allow the
primer to amplify the template DNA. The next 33 cycles followed a two-step PCR
protocol with a higher annealing temperature in order to retain higher specificity for
annealing the entire primer. We verified all amplification of each fragment through gel
electrophoresis (see figure 6). Once all three fragments were successfully amplified, we
combined them in the appropriate ratio for a digestion/ligation reaction following a
Golden Gate cloning protocol (New England Biolabs, Golden Gate). We are currently in
the process of transforming bacteria with resulting plasmids to be sent for sequencing.
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a

Figure 6. Gel Verification The individual fragments were amplified using PCR and verified on a 1%
agarose gel. In panel a, the top lanes show amplification of the gfp from genomic DNA from genetically
zebrafish. Lanes 1 and 8 are 100 bp ladders, while lanes 2-7 and 9-14 are multi-stage gradient PCRs
from two different fish genomes. The gfp gene appears at 716 bp. The lower lanes of panel A show a 1
kb ladder in lane 2, along with a multi-stage gradient PCR amplification of the plasmid using the cmlc2
library as a template in lanes 3 - 8. The primers were designed to amplify the entire plasmid except for
the inserted cmlc2 and gfp/barcode regions, resulting in a product of 3680 bp. Panel b shows the multistage gradient PCR amplification of the vmhc promoter from zebrafish genomic DNA. Lane 1 is a 1 kb
ladder. The vmhc promoter fragments are the faint lines at 1.9 kb. The lower bands are where we
estimate some primer dimers may have formed.

Future Directions
Upon verification of the successful ligation of all three fragments into a plasmid
library, we will send the library for PacBio HiFi sequencing. Following the same strategy
for the cmlc2 gene, we will verify the mutagenic rate in the amplification of the vmhc
promoter and check the coverage of variants throughout the length of the promoter. From
there, we will follow the same procedure described above to identify functionally
important areas of the general upstream vmhc promoter.
We will also work to identify binding sites of known transcription factors and
compare their binding sites to the regions of interest identified by this new process. The
validation of this method has made important progress for our ability to analyze
promoters. We next aim to characterize the atrial myosin heavy chain (amhc) promoter
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and then compare transcription factor binding sites among the cmlc2 (whole heart), vmhc
(ventricular), and amhc (atrial) to investigate possible similarities and differences in the
transcription machinery driving the spatial expression of these three cardiac genes.
Future experiments could apply this technique to other tissue-specific promoters outside
the heart or promoters that become active at later stages of development. Additionally,
further studies are needed to investigate the usefulness of this technique for
characterizing mammalian promoters in zebrafish. The continual development of this
method to rapidly analyze promoter regions will push us towards a greater understanding
of gene regulatory regions and provide insights into the regulatory mechanisms that
control all gene expression.
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IV. Materials and Methods
Faulty PCR (for the cmlc2 promoter)
To create the mutant cmlc2 promoter library, the following protocol was followed to
introduce mutations during the Taq PCR. Each buffer and dNTP/dGTP was taken from
Takara Diversify PCR Random Mutagenesis Kit (Takara Biolabs).
39 uL of PCR grade water
5 uL of 10x titanium taq buffer (provided in kit)
1 uL of 8 mM MnSO4
1 uL of dGTP (2 mM)
1 uL of 50x Diversify dNTP Mix (10 mM in each of dATP, dGTP, dTTP, and dCTP)
1 uL Primer Mix (10 uM)
1 uL Template Mix (at a concentration of 1 ng/uL)
1 uL Titanium Taq Polymerase (at a concentration of 20 units/ uL)

94 ℃ for 30 seconds
25 cycles of:
94 ℃ for 30 seconds
60 ℃ for 1 minute
68 ℃ for 1 minute
68 ℃ for 1 minute
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Faulty PCR (for the vmhc promoter)
To make the vmhc mutated promoter library, a “master mix” was created for 6 PCR
reactions using the following reagents. All reagents came from the Takara Diversify
PCR Random Mutagenesis Kit (Takara Biolabs).
280 uL RNase Free H20
35 uL Titanium Taq Buffer (from kit)
7 dGTP Mix (2 mM)
7 uL Diversify dNTP (10 mM in each of dATP, dGTP, dTTP, and dCTP)
14 uL primers (10 uM)
7 uL template DNA - (at a concentration of 1 ng/uL) We used a previous vmhc
promoter PCR product, which had a faint band indicating some amplification of vmhc.
That PCR product was amplified a second time in order to increase the yield
49 uL of the “master mix” was placed into 6 PCR tubes, to which was added 1 uL of
Taq polymerase to each tube. The thermocycler was programmed as follows:
95 ℃ - 3:00 min
7 cycles of:
95 ℃ - 30 seconds
58 ℃ - 70 C Gradient - 30 seconds
68 ℃ - 2:00 minutes
33 cycles of:
95 ℃ - 30 seconds
68 ℃ - 2:00 minutes
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Final extension:
68 ℃ - 10:00

Analysis by Gel Electrophoresis
All gels were made by combining 50 mL 1X TAE buffer with 50 mg agarose to create a
1% agarose gel. The agarose was dissolved in the buffer by heating the buffer in a
microwave, then 3 uL of ethidium bromide were added before the gel was formed in the
mold. The cooled gel was loaded with samples and ladder, then run at a constant 120 V
for 20-25 minutes. Imaging was done using FluorChem Analysis Software.

Fin Clip for Zebrafish Genomic DNA Exposure
10 ml of Tricaine was added to 250 ml fish system water in a beaker, and a sterilized
recovery tank for the fish was prepared with fresh system water. A single fish was
selected and introduced it to the tricaine solution. Once the fish stopped swimming, it was
placed in a plastic petri dish. A small section of the tail was carefully removed using a
clean razor blade, and the tail clip was placed into a PCR tube. The fish was immediately
transferred to the clean recovery tank, and water was gently moved past its gills until the
fish began to swim again. After 24 hours, the fish was reintroduced to its original tank.

100ul of 25 mM NaOH (50mg/50mL) was then added to the PCR tube containing the fin
clip. The sample was incubated at 95 ℃ for 25 minutes, then neutralized with 10 uL of 1
M Tris HCl and vortexed.

23

Heart Injections
The following were mixed, then injected into zebrafish embryos within 1 hpf by using
an air pressurized micro-injector:
3.5 ul H2O
2.0 ul Library (concentration was 72ng/ul)
0.5 ul Phenol Red (a dye to visualize injections)

Heart Tissue RNA extraction
The heart tissues were extracted following the protocol published by Burns & MacRae
(2006). Additionally, we had the advantage because our reporter gene was gfp, so any
heart tissues we needed to collect fluoresced green under UV light. The hearts were
isolated behind black out curtains in order to facilitate this process.

Confidence Interval Calculation for Baseline Expression Frequency of cmlc2
𝐶𝐼 = 𝑥̅ ± 𝑍𝛼/2

𝜎
√𝑛

Where 𝑥̅ is the mean expression level of the non-mutated promoters, Z is a z-score taken
𝛼

from a normal distribution for the critical value of 2 , 𝜎 is the standard deviation of the
non-mutated promoters, and 𝑛 is the number of barcodes that corresponded to nonmutated promoters.
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Golden Gate Primers for vmhc Promoter Analysis
The vmhc primers were ordered to replicate the same promoter analyzed in Jin et al
(2009). Additionally, the BsmB1 restriction site was added to the 5’ end of each primer,
along with an additional ATCG in order to prevent the restriction site from starting at
the 5’ edge of the DNA. The addition of the four bases allows more of a landing for the
enzyme to recognize its target sequence and bind. The reverse gfp primer also included
a 10-base degenerate barcode. The barcode was moved to the 3’ end of the gfp
transcript to eliminate any interference with transcription that may have occurred when
the barcode was placed in the 5’ UTR.
vmhc
Forward Primer
5′-ATCGCGTCTCNCCCTACTCCGCGGAGGCCATGTGTCCTAAATTCTG -3’
Reverse Promoter
5′-ATCGCGTCTCNGTGGATCGGATCCGAACACCAACCATGAGATCACT-3’

gfp/BARCODE
Forward: 5′-ATCGCGTCTCNCCACGTGAGCAAGGGCGAGGAGC-3’
Reverse: 5' –
ATCGCGTCTCNCGCTNNNNNNNNNNACTTGTACAGCTCGTCCATGCC-3’

Plasmid Backbone:
Forward: 5'- ATCGCGTCTCNAGCGGCCCCTCTCGAGCCTCTAG-3’
Reverse: 5'- ATCGCGTCTCAAGGGCGAATTCCAGCACAC-3’
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PCR Parameters for Phusion PCR (gfp and Plasmid Amplification Using Multi-Step
Gradient PCR)
For each reaction, a “master mix” was created for 6 PCR reactions that contained the
following.
24 uL 5X GC Buffer
4.8 uL 10uM dNTP
12 uL primer working stock (10uM)
6 uL template (1 ng/uL minimum)
74.4 uL ddH2O

The template DNA came from a fin clip (for gfp) or from a plasmid library (for the
vmhc promoter analysis, the plasmid fragment was amplified from the cmlc2 promoter
library).

19.9 uL of the master mix was then put into each of 6 PCR tubes, and 0.5 uL of phusion
protein added to each tube while on ice.
The multi-step gradient PCR parameters are as follows:

95 ℃ - 3:00 min
7 cycles of:
95 ℃ - 30 seconds
58 ℃ - 70 C Gradient - 30 seconds
72 ℃ - 2:00 minutes
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33 cycles of:
95 ℃ - 30 seconds
72 ℃ - 2:00 minutes
Final extension:
72 ℃ - 10:00

The cycles were changed to follow a two-step PCR after the first seven cycles because
at that it was believed that the original template would have all been replicated, so the
primers would be able to anneal along their whole length at an annealing temperature
above 72 ℃.

Golden Gate Digestion/Ligation Protocol
Golden Gate assembly with BsmB1 was carried out according to the NEB Golden Gate
Assembly protocol (New England Biolabs. Golden Gate (24 Fragment) Assembly
Protocol). We combined the following into PCR tubes on ice:
17.5 uL RNase free H2O
1 uL plasmid (75 ng/uL)
1 uL gfp (30 ng/uL)
1 uL vmhc promoter (40 ng/uL)
2.5 uL T4 DNA ligase 10X buffer from NEB T4 DNA Ligase kit
0.5 uL T4 DNA ligase from NEB T4 DNA Ligase kit
1.5 uL BsmB1 restriction enzyme (10,000 Units/mL)
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The solution was mixed by pipetting gently several times, then placed in the thermocycler
and run under the following cycle:

5 min – 37 ℃
5 min – 16 ℃

Repeated for 30 cycles. Since the sample was stored overnight in the freezer, an
additional 5 min 60 ℃ step was run before transforming bacteria, per protocol
instructions.
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Appendix I:
Analysis of Pacbio Sequencing of cmlc2 Library
We sequenced the Promoter library using PacBio Sequencing at UCSD. We next
needed to analyze the results to determine the complexity and nature of the library.

Import subreads
Called ccs reads on files with the following commands:
~/smrtlink/smrtcmds/bin/bax2bam -o promoterseqs *.bax.h5
~/smrtlink/smrtcmds/bin/ccs promoterseqs.subreads.bam promoterccs.bam

Now read bam file into R:
library(Rsamtools)
# specify the bam file you want to import
bamFile <- "./PacBio Sequencing/Analysis_Results/promoterccs_header.bam
"
# A function to read bam file
readBAM <- function(bamFile){
bam <- scanBam(bamFile)
# A function for collapsing the list of lists into a single list
# as per the Rsamtools vignette
.unlist <- function (x){
x1 <- x[[1L]]
if (is.factor(x1)){
structure(unlist(x), class = "factor", levels = levels(x1))
} else {
do.call(c, x)
}
}
bam_field <- names(bam[[1]])
list <- lapply(bam_field, function(y) .unlist(lapply(bam, "[[", y)))
bam_df <- do.call("DataFrame", list)
names(bam_df) <- bam_field
#return a list that can be called as a data frame
return(bam_df)
}
# Load the bam file
bam1 <- readBAM(bamFile)
# Get sequences (only part that matters)
seqs1 <- bam1$seq
write.table(seqs1, "~/PacBio_Sequencing/Analysis_Results/allseqsnew.txt
")

Flip Reverse Complement Reads
We expect about half of the reads will be on opposite strand. Need to flip those
around.
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numforward <- sum(grepl("TGAGCAAGGG", seqs1))
numreverse <- sum(grepl("CCCTTGCTCA", seqs1))
print(paste("number on forward strand:", numforward))
print(paste("number on reverse strand:", numreverse))
print(paste("total with properbarcode:", numforward + numreverse, "out
of", length(seqs1)))
rcomps <- grepl("CCCTTGCTCA", seqs1)
seqs1[rcomps] <- reverseComplement(seqs1[rcomps])

Get Barcodes and Promoters
We need to compile all of the barcodes and cmlc2 promoter sequences for analysis.
barcodes <- gsub(".*GATTACACCACCATG(.*)GTGAGCAAGGGCGAG.*", "\\1", seqs1
)
seqsdf <- data.frame(seq = seqs1, barcode = barcodes, stringsAsFactors
= FALSE)
seqsdf <- seqsdf[nchar(seqsdf$barcode) < 25, ]
hist(nchar(seqsdf$barcode), breaks = 24)
length(unique(seqsdf$barcode))

Align to reference
library(Biostrings)
library(ggplot2)
WTSeq <- "AAAGCTTAAATCAGTTGTGTTAAATAAGAGACATTCAAAATAAATGTAAATGAGCTCTCCA
AATCAGCAGACTTAACATTCTTTAAAATGATTGATTCAATAGTGATAAAAATCAGGCATAGCCAGTTGTAA
CTTTAGATAAATTACAGAAAATGTCAAATACAGAGAACCGATTCTTTTTTATGATACATCCAAGCACACAT
TTAACACAATCCAGGCAAACCCCGAATTTCACAGTCACAAGCACTGTTTGTACAAGAGCTTTGCCTAAGGA
CACACAGTCTCTATAAGTCCAGGTCGTTGGTTTCACTCTTATTTTAAACATGTGACATTTTTCCTGCCATC
CTGTCTTAGGCTGCTGTTTGCTTCATTCCATGTCACATTAAATTCCTCAGTAGCACCTTTTACACACACAG
CCAATCTTTTCCAGAAAATTCAATTGCTTTGAAGAGATAATGTGTGAACAAATCCATTTAGAAAAGGAAAA
TTAAGAATTTGTAAAATCATCTGTAAATTGTTGGCATTCTTCTGTATATGAACATCACATCATTTACAGGT
AAAGGTCTGGTCATTAATTATATGACAATTTACTGGTATTATTTTGTGAAAGGGGCTATTTTCAATGCGTT
CATCCATCCTTTTCATCCCTCAAATCTCTCATTCACGTCCCCCTCCCCATCTGCACACTTTATCTCATTTT
CCACCCTGCTGGAATCTGAGCACTTGTGCAGTTATCAGGGCTCCTGTATTTAGGAGGCTCTGGGTGTCCAT
GTAGGGGACGAACAGAAACACTGCAGACCTTTATAGAAGAACAATTGATAAGAGTCCTCATACATAAAGAC
TCCATTAGTAAGCCAGTGACCCAGGAGCCCAGACCAACAGCAAAGCAGACAGTGACC"
alignments <- pairwiseAlignment(seqsdf$seq, WTSeq, type = "overlap")
mismatches <- data.frame(number = nmismatch(alignments))
table(mismatches$number)
g1 <- ggplot(mismatches, aes(x = number)) +
geom_histogram(binwidth = 1, center = 0, color = "red4", fill = "red3
") +
scale_x_continuous(minor_breaks = seq(0 , 10, 1), breaks = seq(0, 10,
2), limits = c(-.5, 10.5)) +
xlab("Number of Mutations in Construct")
g1
ggsave("Numbermutations.png", g1, "png", width = 5.5, height = 4.5, uni
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ts = "in", dpi = 300)
mean(nmismatch(alignments)[nmismatch(alignments) < 10])
which(nmismatch(alignments) > 100)
writePairwiseAlignments(alignments[20856])
mismatchlocs <- mismatchTable(alignments[nmismatch(alignments) < 10])
mismatchlocs
g2 <- ggplot(mismatchlocs, aes(x = SubjectStart)) +
geom_histogram(binwidth = 1, color = "blue3", fill = "blue3") +
scale_x_continuous(minor_breaks = seq(0 , 1200, 25), breaks = seq(0,
1200, 50), limits = c(0, max(mismatchlocs$SubjectStart))) + xlab("Posit
ion in Construct (bases from start)")
g2
ggsave("Mutatedpositions.png", g2, "png", width = 5.5, height = 4.5, un
its = "in", dpi = 300)
which(!(1:max(mismatchlocs$SubjectStart) %in% mismatchlocs$SubjectStart
))
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Appendix II:
Analysis of Extracted Barcode Sequences Using R
By Julie Ann Goddard and Hunter Giles

READ FILES
#install.packages("ShortRead")
library(ShortRead)
library(dplyr)
reads1 <- sread(readFastq("~/PromoterBasher/PromoterShare/Files", patte
rn = "17326X1"))
reads2 <- sread(readFastq("~/PromoterBasher/PromoterShare/Files", patte
rn = "17326X2"))
reads3 <- sread(readFastq("~/PromoterBasher/PromoterShare/Files", patte
rn = "17326X3"))
## MAKE SURE ALL FILES CONTAIN THE BARCODE (105,759,882/245,461,452 rea
ds contain the barcode)
wBarcode1 <- grep("CCATGG(?:..G){4}..GTGAGC", reads1, value = TRUE) # 2
9346534/71623676 (41.0%)
wBarcode2 <- grep("CCATGG(?:..G){4}..GTGAGC", reads2, value = TRUE) # 3
1818341/77256226 (41.2%)
wBarcode3 <- grep("CCATGG(?:..G){4}..GTGAGC", reads3, value = TRUE) # 4
3771679/96581550 (45.3%)
# another way to do but in only one step:
# wBarcode1 <- gsub(".*CCATGG((?:..G){4}..)GTGAGC.*", "\\1", reads1
)
## COMBINE ALL BARCODES INTO ONE VARIABLE
allReadswBarcode <- c(wBarcode1, wBarcode2, wBarcode3)

EXTRACT UNIQUE BARCODES
## COUNT AND ISOLATE EACH UNIQUE BARCODE
#install.packages("stringr") (we have 146,474 unique barcodes)
RNAseq_barcodes <- stringr::str_extract(string = allReadswBarcode, patt
ern = "CCATG.{15}GTGAGC")
RNAseq_barcodes <- substr(RNAseq_barcodes, 6, 20)
RNAseq_unique_barcodes <- unique(RNAseq_barcodes)

COUNT HOW MANY OF EACH BARCODE; MAKE DATA
FRAME AND PLOT
allBarcodesCount <- as.data.frame(table(barcodes))
plot(log2(sort(allBarcodesCount$Freq)))

MATCH BARCODES WITH MUTATIONS
matches <- RNAseq_barcodes %in% seqsdf$barcode
sum(matches)
#This shows 81,064,048 barcodes from RNAseq_barcodes (104,936,554 barco
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des total) have matches in the original PacBio seqsdf$barcode sequence
#?#(this is all the barcodes, not just the unique ones?)
barcodes_extracted_in_original_data <- RNAseq_barcodes[matches]
combined_data <- as.data.frame(table(barcodes_extracted_in_original_dat
a))
colnames(combined_data) <- c("ExtractedBarcodes", "Frequency")
str(combined_data)
#At this point the data from the RNAseq results is in a dataframe with
the barcodes as factors in the first column, and the count of the frequ
ency of each of those barcodes in the second column
## MERGE TABLES
seqsdf$PatternId <- 1:nrow(seqsdf)
merge1 <- merge(seqsdf, mismatchlocs, by = "PatternId")
merge2 <- merge(merge1, combined_data, by.x = "barcode", by.y = "Extrac
tedBarcodes")
## GRAPH FREQUENCY OF POSITION
graphData <- merge2 %>%
group_by(SubjectStart) %>%
summarise(mean(Frequency))
#install.packages("ggplot2")
library(ggplot2)
ggplot(graphData, mapping = aes(x = graphData$SubjectStart, y = graphDa
ta$`mean(Frequency)`)) +
geom_point() +
labs(x = "Mutation Position", y = "Frequency")
#install.packages("zoo")
library(zoo)
slidingMean <- rollapply(graphData$`mean(Frequency)`, 15, mean)
ggplot(as.data.frame(slidingMean), mapping = aes(x = 1:length(slidingMe
an), y = slidingMean)) +
geom_line() +
labs(x = "Mutation Position", y = "Barcode Expression Frequency", sub
title = "10 base sliding window mean expressions") +
ggtitle("Frequencies of Barcode Expression \n Compared to Mutation Po
sition") +
theme_bw()
#FIND EXPRESSION FREQUENCY FOR BARCODES WITHOUT MISMATCHES
merge3 <- merge(seqsdf, mismatchlocs, by = "PatternId", all.x = TRUE)
#This dataframe now has all original barcodes, with and without mismatc
h sequences
merge4 <- merge(merge3, combined_data, by.x = "barcode", by.y = "Extrac
tedBarcodes")
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baseline_frequency <- merge4 %>%
filter(is.na(PatternStart)) %>%
select(Frequency)
baseline_frequency <- as.vector(baseline_frequency$Frequency)
summary(baseline_frequency)
#
Min. 1st Qu. Median
Mean 3rd Qu.
Max.
#
1
4436
16011
26039
36416 394999
#99% CONFIDENCE INTERVAL FOR BASELINE
x_bar <- mean(baseline_frequency)
sd_x <- sd(baseline_frequency)
sqrt_n <- sqrt(length(baseline_frequency))
alpha <- 0.01
ci <- x_bar + c(-1, 1) * qnorm(1 - alpha/2) * sd_x / sqrt_n
#New Plot with baseline rate
ggplot(as.data.frame(slidingMean), mapping = aes(x = 1:length(slidingMe
an), y = slidingMean)) +
geom_line() +
labs(x = "Mutation Position", y = "Barcode Expression Frequency", sub
title = "10-base sliding window mean expression with 99% Baseline Confi
dence Interval (in blue)") +
ggtitle("Frequencies of Barcode Expression Compared to Mutation Posit
ion") +
theme_minimal() +
scale_x_continuous(breaks = seq(from = 0, to = 900, by = 50)) +
geom_ribbon(aes(ymin = ci[1], ymax = ci[2]), alpha = 0.5, fill = "dod
gerblue")
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